Studies of the immune basis of MS or its animal model, experimental autoimmune encephalomyelitis (EAE), have largely been directed toward the study of Th1 and Th17 effector CD4 T cells mediating pathology, while fewer studies have addressed the involvement of CD8 T cells in disease development and regulation. Here, CD8A is linked to myeloid sarcoma.